Ubs Asset Management Americas Inc Prothena Corp Public LTD CO Transaction History
Ubs Asset Management Americas Inc
- $477 Billion
- Q2 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 139,284 shares of PRTA stock, worth $1.05 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
139,284
Previous 381,652
63.5%
Holding current value
$1.05 Million
Previous $4.72 Million
82.11%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding PRTA
# of Institutions
212Shares Held
33.5MCall Options Held
848KPut Options Held
648K-
Black Rock Inc. New York, NY3.86MShares$29.1 Million0.0% of portfolio
-
Adar1 Capital Management, LLC Austin, TX3.38MShares$25.4 Million3.14% of portfolio
-
Armistice Capital, LLC New York, NY2.24MShares$16.9 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.18MShares$16.4 Million0.0% of portfolio
-
Palo Alto Investors LP Palo Alto, CA1.27MShares$9.61 Million1.75% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $354M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...